This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Healthcare Europe

BD announces UK launch of new BD Nexiva Closed IV Catheter System

28 July, 2009  

BD Medical, a segment of BD (Becton, Dickinson and Company), announced today the UK launch of the latest BD Nexiva Closed IV Catheter System designed to reduce healthcare workers’ risk of needlestick injuries and minimise exposure to blood.

The system includes the BD Q-SyteTM Luer Access Split Septum to help reduce catheter-related bloodstream infections (CRBSIs). The new version of the BD Nexiva system introduces key developments, including:

  • New non-removable pinch clamp for easy, one-handed activation
  • Soft stabilisation platform designed to decrease catheter movement and associated complications, whilst providing greater patient comfort
  • New catheter grip design which accommodates the various insertion techniques employed by clinicians
  • Larger bore extension tubing on 18G and 20G cannulas for improved flow rates

“BD continues to grow its portfolio of innovative products designed to help healthcare organisations in the UK and around the world protect their healthcare workers and patients from infection,” said Suzanne Grant, Business Director, BD Medical – Medical Surgical Systems.

“The latest BD Nexiva Closed IV Catheter System reflects our ongoing efforts to improve clinical efficacy and patient comfort in infusion therapy – it not only simplifies the IV therapy process, but also is designed to remove some typical sources of risk.”  

Studies have shown that needlestick injuries are a significant risk to the physical and psychological health of nurses, and cause significant additional costs to healthcare provision .

Used for peripheral venous access, the all-in-one BD Nexiva system is designed to reduce insertion attempts and limit healthcare workers’ exposure to blood with its innovative blood-containment system that helps minimise blood leakage from the catheter hub. This safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology that does not compromise the insertion techniques.  

Studies in Europe have estimated that the associated costs of CRBSIs may be hundreds of millions of euros. An important feature incorporated into the BD Nexiva Closed IV Catheter System is the BD Q-Syte Luer Access Split Septum, which offers a straight and unobstructed fluid path, high flow rates, clear visibility and cleanability.

A split septum needle access system has 64-70% lower CRBSI rates than mechanical valves. By eliminating the complexities of mechanical valves, this split-septum device helps reduce the number of places where bacteria may thrive. In fact, comparison studies found that patients are three times more likely, on average, to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.